Use of Neonatalyte in the first 24 hours of life.
Explore the source record for details and available documents.
Fluid Therapy↗
Biomedical subjects
Publications and source records attributed to C C Lombard.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Newborns in the neonatal unit at Ga-Rankuwa Hospital who required intravenous fluids were randomly allocated, after 24 hours of life, to receive either Neonatalyte (Sabax) or a control solution. Biochemical monitoring was performed every 12 hours for a period of 5 days. Neonatalyte does not cause hyperkalaemia or hypocalcaemia in the early neonatal period.